(Q36615636)

15 August 2017

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer (English)

1 reference

15 August 2017

1 reference

1 reference

S L Lim

1

1 reference

15 August 2017

P Smith

2

1 reference

15 August 2017

N Syed

3

1 reference

15 August 2017

C Coens

4

1 reference

15 August 2017

H Wong

5

1 reference

15 August 2017

M van der Burg

6

1 reference

15 August 2017

P Szlosarek

7

1 reference

15 August 2017

T Crook

8

1 reference

15 August 2017

J A Green

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

15 April 2008

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

98

1 reference

15 August 2017

1452-1456

1 reference

15 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604325

15 August 2017

0 references

cites work

Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

The Fanconi anaemia/BRCA pathway

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Second-line treatment of ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361708

Nonparametric Estimation from Incomplete Observations

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604325

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

21 January 2018

1 reference

12 December 2020

A simplified method to culture human ovarian surface epithelium

1 reference

12 December 2020

Cisplatin and the sensitive cell

1 reference

12 December 2020

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604325

1 reference

15 August 2017

1 reference

15 August 2017

1 reference